Skip Nav Destination
Close Modal
Update search
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
Filter
- Title
- Author
- Author Affiliations
- Full Text
- Abstract
- Keyword
- DOI
- ISSN
- EISSN
- Issue
- Volume
- References
NARROW
Format
Article Type
Date
Availability
1-15 of 15
Keywords: C-reactive protein (CRP)
Close
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Sort by
Articles
Ying Tang, Xiao Ru Huang, Jun Lv, Arthur Chi-Kong Chung, Yang Zhang, Jun-Zhe Chen, Alexander J. Szalai, Anping Xu, Hui Y. Lan
Journal:
Clinical Science
Clin Sci (Lond) (2014) 126 (9): 645–659.
Published: 14 January 2014
... There are three new and significant findings from the present study: (i) CRP is not only a biomarker for, but also a pathogenic mediator in, AKI; (ii) CRP promotes AKI by inhibiting G 1 /S-dependent TEC regeneration; and (iii) blockade of CRP signalling attenuates AKI. acute kidney injury (AKI) C-reactive...
Includes: Supplementary data
Articles
Leonard P. van der Zwan, Peter G. Scheffer, Jacqueline M. Dekker, Coen D. A. Stehouwer, Robert J. Heine, Tom Teerlink
Journal:
Clinical Science
Clin Sci (Lond) (2011) 121 (2): 71–78.
Published: 04 April 2011
...-reactive protein (CRP) inflammation myeloperoxidase (MPO) NO synthase (NOS) oxidative stress Endothelium-derived NO, which is synthesized from arginine by NOS (NO synthase), is an important regulator of vascular homoeostasis. In addition to being a powerful endogenous vasodilator, NO inhibits...
Articles
Patricia H.C. Rondó, Jesuana O. Lemos, Joilane A. Pereira, Julicristie M. Oliveira, Luiz Roberto Innocente
Journal:
Clinical Science
Clin Sci (Lond) (2008) 115 (10): 317–326.
Published: 15 October 2008
... blood pressure cardiovascular disease childhood C-reactive protein (CRP) ‘Fetal programming’ or the ‘hypothesis of fetal origin of adult diseases’ suggests that stimuli or injuries that occur during the critical periods of development may permanently modify the structure, physiology...
Articles
Arschang Valipour, Martin Schreder, Michael Wolzt, Sleman Saliba, Sonja Kapiotis, Philipp Eickhoff, Otto Chris Burghuber
Journal:
Clinical Science
Clin Sci (Lond) (2008) 115 (7): 225–232.
Published: 03 September 2008
... 29 2 2008 © The Authors Journal compilation © 2008 Biochemical Society 2008 cardiovascular disease chronic obstructive pulmonary disease (COPD) C-reactive protein (CRP) systemic inflammation vascular endothelial growth factor VEGF) VEGF (vascular endothelial growth factor...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 113 (2): 79–81.
Published: 13 June 2007
... Society 2007 C-reactive protein (CRP) cytokine inflammation insulin resistance interleukin lipopolysaccharide Type 2 diabetes There is firm evidence that atherosclerosis is an immune-mediated inflammatory disease [ 1 ]. The nature of the atherosclerotic process can be described...
Articles
Giovanna Castoldi, Stefania Galimberti, Chiara Riva, Ruggero Papagna, Federico Querci, Marco Casati, Gianpaolo Zerbini, Gianluigi Caccianiga, Carlo Ferrarese, Marco Baldoni, Maria Grazia Valsecchi, Andrea Stella
Journal:
Clinical Science
Clin Sci (Lond) (2007) 113 (2): 103–108.
Published: 13 June 2007
... giovanna.castoldi@unimib.it ). 29 11 2006 1 3 2007 16 3 2007 16 3 2007 © 2007 The Biochemical Society 2007 C-reactive protein (CRP) cytokine inflammation insulin resistance interleukin lipopolysaccharide Type 2 diabetes Epidemiological studies indicate that diabetes...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (11): 543–555.
Published: 01 May 2007
..., endothelial cell; FC, foam cell; mΦ, macrophage; OC, osteocalcin; OP, osteopontin; Th, T-helper cell. antioxidant cardiovascular disease C-reactive protein (CRP) cytokine exercise inflammation vascular wall It is well established that physically fit individuals have a reduced risk...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (8): 449–456.
Published: 13 March 2007
... with the ECG data during acquisition. HF power for variability in respiration was calculated with MATLAB, as described above. The Biochemical Society 2007 behavioural relaxation cardiovascular disease C-reactive protein (CRP) heart rate variability inflammation stress Vagal efferent...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2007) 112 (5): 305–314.
Published: 01 February 2007
...@temple.edu ). 27 2 2006 10 10 2006 25 10 2006 25 10 2006 The Biochemical Society 2007 C-reactive protein (CRP) cytokine interleukin musculoskeletal disorder overuse injury tumour necrosis factor (TNF) upper-body musculoskeletal assessment According to the most...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (6): 493–495.
Published: 24 May 2005
... 2005 30 3 2005 The Biochemical Society 2005 atherosclerosis C-reactive protein (CRP) interleukin-8 mitogen-activated protein kinase (MAPK) 3-hydroxy-3-methylglutaryl-CoA (HMG-CoA) reductase inhibitor statin Atherosclerosis is currently regarded as a dynamic and progressive...
Articles
Eun-Jung RHEE, Won-Young LEE, Se-Yeon KIM, Byung-Jin KIM, Ki-Chul SUNG, Bum-Su KIM, Jin-Ho KANG, Ki-Won OH, Eun-Sook OH, Ki-Hyun BAEK, Moo-Il KANG, Hee-Yeon WOO, Hyo-Soon PARK, Sun-Woo KIM, Man-Ho LEE, Jung-Roe PARK
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (3): 237–243.
Published: 18 February 2005
... to the ethical guidelines of the Declaration of Helsinki, and the study received approval by the Institution's Human Research Committee. atherosclerosis coronary artery disease C-reactive protein (CRP) left ventricular mass index osteoprotegerin Height, weight, waist circumference and the systolic...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (2): 121–128.
Published: 21 January 2005
...-diabetic patients, which may only partly be explained by traditional risk factors. Our purpose was to compare non-traditional risk factors, such as endothelial function, C-reactive protein (CRP) and adiponectin, in Type II diabetic and non-diabetic patients following AMI (acute myocardial infarction...
Articles
Marta ESCRIBANO-BURGOS, Antonio LÓPEZ-FARRÉ, María del MAR GONZÁLEZ, Carlos MACAYA, Antonio GARCÍA-MÉNDEZ, Petra J. MATEOS-CÁCERES, Sergio ALONSO-ORGAZ, Carolina CARRASCO, Luis A. RICO, Juan Carlos PORRES CUBERO
Journal:
Clinical Science
Clin Sci (Lond) (2005) 108 (1): 85–91.
Published: 15 December 2004
... ]. Indeed, recent studies suggest that CRP is not merely a marker of inflammation and atherosclerosis, but actively participates in the lesion formation inducing leucocyte activation [ 5 ]. CD32 receptor C-reactive protein (CRP) endothelium endothelial nitric oxide synthase (eNOS) inflammation...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2004) 106 (5): 443–445.
Published: 01 May 2004
... (e-mail nsattar@clinmed.gla.ac.uk ). 19 1 2004 26 1 2004 26 1 2004 © 2004 The Biochemical Society 2004 C-reactive protein (CRP) cytokine endothelial function inflammation serum secretory non-pancreatic type II phospholipase A2 (sPLA2) Clinical Science (2004) 106...
Articles
Journal:
Clinical Science
Clin Sci (Lond) (2004) 106 (5): 511–517.
Published: 01 May 2004
... The Biochemical Society 2004 coronary artery disease C-reactive protein (CRP) endothelial function forearm blood flow inflammation secretory non-pancreatic type II phospholipase A2 (sPLA2) Clinical Science (2004) 106, 511 517 (Printed in Great Britain) 511 Elevated secretory non-pancreatic type II...